Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Alembic Pharmaceuticals Limited ( (IN:APLLTD) ) is now available.
Alembic Pharmaceuticals Limited announced a change in its auditors following the approval at its 15th Annual General Meeting. The company appointed M/s. KKC & Associates LLP as its new Statutory Auditors and M/s. Samdani Shah & Kabra as its Secretarial Auditors, both for a term of five years. This change in auditors is part of the company’s compliance with regulatory requirements and may impact its financial reporting and governance practices.
More about Alembic Pharmaceuticals Limited
Alembic Pharmaceuticals Limited operates in the pharmaceutical industry, focusing on the development, manufacturing, and marketing of pharmaceutical products. The company is known for its range of generic formulations and active pharmaceutical ingredients, catering to both domestic and international markets.
Average Trading Volume: 29,210
Technical Sentiment Signal: Strong Buy
Current Market Cap: 188.3B INR
See more data about APLLTD stock on TipRanks’ Stock Analysis page.